Sanofi to Transfer Plaquenil’s Japan Marketing Rights to Asahi Kasei on Oct. 1

Sanofi will transfer the Japanese marketing rights of its immunomodulating agent Plaquenil (hydroxychloroquine sulfate) to Asahi Kasei Pharma, the two companies said on July 19. Under the terms of a licensing agreement, Sanofi will remain the marketing authorization holder and...read more